Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats
Umbilical cord mesenchymal stem cells (UCMSCs) are a reportedly promising choice in the treatment of irreversible pulmonary fibrosis and lethal interstitial lung disease with limited drug treatment options. In this study, we investigated the therapeutic efficacy of UCMSCs overexpressing hepatocyte g...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1070736/full |
| _version_ | 1797951838098554880 |
|---|---|
| author | Huanjie Chen Yulong Luo Yiping Zhu Yongshun Ye Difei Chen Xinyu Song Zhulin Xiao Ming Liu Shiyue Li |
| author_facet | Huanjie Chen Yulong Luo Yiping Zhu Yongshun Ye Difei Chen Xinyu Song Zhulin Xiao Ming Liu Shiyue Li |
| author_sort | Huanjie Chen |
| collection | DOAJ |
| description | Umbilical cord mesenchymal stem cells (UCMSCs) are a reportedly promising choice in the treatment of irreversible pulmonary fibrosis and lethal interstitial lung disease with limited drug treatment options. In this study, we investigated the therapeutic efficacy of UCMSCs overexpressing hepatocyte growth factor (HGF), which is considered one of the main anti-fibrotic factors secreted by MSCs. Adenovirus vector carrying the HGF gene was transfected into UCMSCs to produce HGF-modified UCMSCs (HGF-UCMSCs). Transfection promoted the proliferation of UCMSCs and did not change the morphology, and differentiation ability, or biomarkers. Rats were injected with HGF-UCMSCs on days 7 and 11 after intratracheal administration of bleomycin (10 mg/kg). We performed an analysis of histopathology and lung function to evaluate the anti-fibrotic effect. The results showed that HGF-UCMSCs decreased the Ashcroft scores in hematoxylin and eosin-stained sections, the percentage positive area in Masson trichrome-stained sections, and the hydroxyproline level in lungs. Forced expiratory volume in the first 300 m/forced vital capacity was also improved by HGF-UCMSCs. To explore the possible therapeutic mechanism of HGF-UCMSCs, we detected inflammatory factors in the lungs and performed mRNA sequencing in UCMSCs and HGF-UCMSCs. The data indicated that inhibition of interleukin-17 in the lung may be related to the anti-fibrosis of HGF-UCMSCs, and overexpressed HGF probably played a primary role in the treatment. Collectively, our study findings suggested that the overexpression of HGF may improve the anti-fibrotic effect of UCMSCs through directly or indirectly interacting with interleukin-17-producing cells in fibrotic lungs. |
| first_indexed | 2024-04-10T22:36:52Z |
| format | Article |
| id | doaj.art-07b26c61723046ecabba9dbb62bfaef4 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-04-10T22:36:52Z |
| publishDate | 2023-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-07b26c61723046ecabba9dbb62bfaef42023-01-16T09:36:14ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-01-011310.3389/fphar.2022.10707361070736Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in ratsHuanjie Chen0Yulong Luo1Yiping Zhu2Yongshun Ye3Difei Chen4Xinyu Song5Zhulin Xiao6Ming Liu7Shiyue Li8State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaInnovation Centre for Advanced Interdisciplinary Medicine, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaHuizhou Municipal Central Hospital, Guangzhou, Guangdong, ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaUmbilical cord mesenchymal stem cells (UCMSCs) are a reportedly promising choice in the treatment of irreversible pulmonary fibrosis and lethal interstitial lung disease with limited drug treatment options. In this study, we investigated the therapeutic efficacy of UCMSCs overexpressing hepatocyte growth factor (HGF), which is considered one of the main anti-fibrotic factors secreted by MSCs. Adenovirus vector carrying the HGF gene was transfected into UCMSCs to produce HGF-modified UCMSCs (HGF-UCMSCs). Transfection promoted the proliferation of UCMSCs and did not change the morphology, and differentiation ability, or biomarkers. Rats were injected with HGF-UCMSCs on days 7 and 11 after intratracheal administration of bleomycin (10 mg/kg). We performed an analysis of histopathology and lung function to evaluate the anti-fibrotic effect. The results showed that HGF-UCMSCs decreased the Ashcroft scores in hematoxylin and eosin-stained sections, the percentage positive area in Masson trichrome-stained sections, and the hydroxyproline level in lungs. Forced expiratory volume in the first 300 m/forced vital capacity was also improved by HGF-UCMSCs. To explore the possible therapeutic mechanism of HGF-UCMSCs, we detected inflammatory factors in the lungs and performed mRNA sequencing in UCMSCs and HGF-UCMSCs. The data indicated that inhibition of interleukin-17 in the lung may be related to the anti-fibrosis of HGF-UCMSCs, and overexpressed HGF probably played a primary role in the treatment. Collectively, our study findings suggested that the overexpression of HGF may improve the anti-fibrotic effect of UCMSCs through directly or indirectly interacting with interleukin-17-producing cells in fibrotic lungs.https://www.frontiersin.org/articles/10.3389/fphar.2022.1070736/fullumbilical cordmesenchymal stem cellspulmonary fibrosishepatocyte growth factorinterleukin-17 |
| spellingShingle | Huanjie Chen Yulong Luo Yiping Zhu Yongshun Ye Difei Chen Xinyu Song Zhulin Xiao Ming Liu Shiyue Li Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats Frontiers in Pharmacology umbilical cord mesenchymal stem cells pulmonary fibrosis hepatocyte growth factor interleukin-17 |
| title | Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats |
| title_full | Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats |
| title_fullStr | Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats |
| title_full_unstemmed | Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats |
| title_short | Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats |
| title_sort | enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats |
| topic | umbilical cord mesenchymal stem cells pulmonary fibrosis hepatocyte growth factor interleukin-17 |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2022.1070736/full |
| work_keys_str_mv | AT huanjiechen enhancedsecretionofhepatocytegrowthfactorinhumanumbilicalcordmesenchymalstemcellsamelioratespulmonaryfibrosisinducedbybleomycininrats AT yulongluo enhancedsecretionofhepatocytegrowthfactorinhumanumbilicalcordmesenchymalstemcellsamelioratespulmonaryfibrosisinducedbybleomycininrats AT yipingzhu enhancedsecretionofhepatocytegrowthfactorinhumanumbilicalcordmesenchymalstemcellsamelioratespulmonaryfibrosisinducedbybleomycininrats AT yongshunye enhancedsecretionofhepatocytegrowthfactorinhumanumbilicalcordmesenchymalstemcellsamelioratespulmonaryfibrosisinducedbybleomycininrats AT difeichen enhancedsecretionofhepatocytegrowthfactorinhumanumbilicalcordmesenchymalstemcellsamelioratespulmonaryfibrosisinducedbybleomycininrats AT xinyusong enhancedsecretionofhepatocytegrowthfactorinhumanumbilicalcordmesenchymalstemcellsamelioratespulmonaryfibrosisinducedbybleomycininrats AT zhulinxiao enhancedsecretionofhepatocytegrowthfactorinhumanumbilicalcordmesenchymalstemcellsamelioratespulmonaryfibrosisinducedbybleomycininrats AT mingliu enhancedsecretionofhepatocytegrowthfactorinhumanumbilicalcordmesenchymalstemcellsamelioratespulmonaryfibrosisinducedbybleomycininrats AT shiyueli enhancedsecretionofhepatocytegrowthfactorinhumanumbilicalcordmesenchymalstemcellsamelioratespulmonaryfibrosisinducedbybleomycininrats |